Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Hospital Market and MNCs Rose Higher in Q1/2019 amid Growing Uncertainties and N...
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on diciphering the unexpected high growth of urban hospital ... (8/8/2019)
   
China’s Biopharma Strategy: Challenge or Complement to U.S. Industry Competitiveness? (8/21/2019)
Cancer Treatment in China: The Underestimated Opportunity (8/21/2019)
China’s Central Government Introduces Major Policy Incentives and Restraints to the MedTech Industry (8/20/2019)
How to Use China's 2019 Negative Lists (8/16/2019)
China Has Become A CEO-Level Priority for MNC Cos: Trend and Implications (8/14/2019)
Digital Must Deliver Both Speed and Depth (8/12/2019)
Hospital Market and MNCs Rose Higher in Q1/2019 amid Growing Uncertainties and New Policies (8/8/2019)
Pentagon Sees Security Threat in Chinese Drug-Supply Dominance (8/6/2019)
Dealing with the Chinese Challenge: The Case of the Pharma Industry (8/2/2019)
China's Big Data Draws Big Pharma (7/31/2019)
Crowdfunding Can't Cure China's Health Care (7/30/2019)
Investing in China's Healthtech Industry (7/26/2019) (free)
China Drug-Buying Overhaul Triggers a Flood of Profit Warnings (7/26/2019) (free)
Outsourcing in China: How Far Can It Go? (7/24/2019)
Cross-sector Synergy: China Innovation at Merck (7/19/2019)
Study links pollution to increase in bip...  (8/21/2019)
Roxadustat Approved in China for Treatme...  (8/21/2019)
Innovent Enters a Licensing Agreement wi...  (8/21/2019)
Alligator Bio and Biotheus Enter Antibod...  (8/21/2019)
Cancer Research Facilities Become A Targ...  (8/21/2019)
USFDA Grants Priority Review to BeiGene'...  (8/21/2019)
NMPA Approves Additional Indication of R...  (8/21/2019)
CDE Accepts Clinical Trial Application o...  (8/21/2019)
CDE Accepts Clinical Trial Application o...  (8/21/2019)
CMAB and Kintor Announce a New Partnersh...  (8/21/2019)
NHSA and MOHRSS Issue NRDL under the BMI...  (8/20/2019)
Chronic and Aging-related Diseases Cost ...  (8/20/2019)
NMPA Issues the Provisions for Drug Qual...  (8/19/2019)
CitiResearch - China at Inflection Point...  (8/19/2019)
Sanofi Gains Chinese IND Approval for RN...  (8/19/2019)
Pfizer to Absorb Mylan, Creating Global Generic Powerhou...
PhRMA Calls for Trade Deals That Force Countries to Pay ...
IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
Pfizer and GSK Announce JV to Create a Global Consumer H...
Top 25 Global Pharmaceutical Companies by Market Cap 201...
CitiResearch - China at Inflection Point: Big Opportunity for M...
Sinohealth Projects Lower Chinese Pharmaceutical Market Growth ...
IQVIA Market Prognosis Projects 4.8% CAGR for Chinese Pharmaceu...
Chinese Precision Medicine Market Set to Witness a Robust CAGR ...
SMEI: Review of Chinese Terminal Drug Markets in 2010-H1/2019
Roxadustat Approved in China for Treatment of Anemia in CKD ...
Innovent Enters a Licensing Agreement with Lilly to Develop ...
Alligator Bio and Biotheus Enter Antibody Agreement for Grea...
USFDA Grants Priority Review to BeiGene's Zanubrutinib in Pa...
NMPA Approves Additional Indication of Roche’s Breast Cance...
NMPA Issues the Provisions for Drug Quality Sample Testi...
CFDI Issues 2018 Drug Registration Onsite Inspection Rep...
China Restricts Opioid in Move to Tighten Painkiller Con...
Chinese Government Forms National Level Advisory Committ...
China Issues New Action Plan Against Irregularities in H...
Cancer Research Facilities Become A Target of Chinese Hacker...
Healthcare-Related AI Patent Surge in China Reflects Momentu...
China Moves Up in Global Innovation Ranking
U.S. Seeks Extradition of Chinese Scientist in GSK Trade Sec...
CNIPA Issues 2019 Work Guidance on Promoting the High-Qualit...
WuXi STA Shanghai & Changzhou Facilities Pass U....
China Accounted for 67% of India's Bulk Drug Imports in ...
Athenex Voluntarily Suspends Production at Its Chongqing...
China Issues Draft Positive List of Antibacterial Active...
Chinese API Industry's Environmental Shake-up Disrupts V...
CDE Accepts Clinical Trial Application of Gilead’s NASH...
CDE Accepts Clinical Trial Application of Gilead’s NASH...
Sanofi Gains Chinese IND Approval for RNAi Therapy Fitus...
Ascletis Received IND Approval and Management Outlook of...
3SBio's Enbrel Biosimilar To Be Available as Pre-filled ...
Study links pollution to increase in bipolar disorder, d...
NHSA and MOHRSS Issue NRDL under the BMI, WRI and Matern...
Chronic and Aging-related Diseases Cost Over Half of Chi...
China to Enhance Common Medicine Supply through New Meas...
NHC Releases List of Trial Site Cities of Urban Medical ...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Swiss Agrees to Extradite Chinese Scientist to US for Corp...
Recent Executive Moves
Upcoming Event: Measuring Business Impact & ROI
Upcoming Event: Situational Training Needs Analysis
China Launches Nasdaq-style Tech Board in Shanghai, Expe...
Upcoming Event: Microbiome Movement - Drug Development &...
Upcoming Event: Asia-Pacific Pharma IP Leader Summit 201...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON to Hold Pharma China Ann...
  WiCON Publishes the China Phar...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links